Proven Results - Postmenopausal

KISQALI® (ribociclib) + HORMONE THERAPY OR FULVESTRANT

MBC WASN’T IN MY PLANS. BUT I PLAN ON TAKING IT HEAD ON.

Live longer
without disease progression

KISQALI® (ribociclib) tablets along with hormone therapy (eg, letrozole or anastrozole) or fulvestrant is a treatment option for postmenopausal women with HR+, HER2- metastatic breast cancer. Here are some proven results that show how KISQALI may help.

Proven Results With KISQALI